Lexaria Bioscience Corp.: Lexaria Releases Annual Letter from the CEO

KELOWNA, BC / ACCESSWIRE / January 13, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to provide an

Related Keywords

Mexico ,Australia ,Japan ,Tokyo ,United States ,India ,Canada ,America ,John Docherty ,Chris Bunka ,Lexaria Bioscience ,George Jurcic ,Lexaria Dehydra ,Wellness Science Co Ltd ,Co Ltd ,Lexaria Bioscience Corp ,Lexaria Bioscience Corp View ,Drug Administration ,Nasdaq ,Exchange Commission ,European Union ,Company Or Lexaria ,Bioscience Corp ,Investigational New Drug ,Tokyo Stock Exchange Listed ,North America ,Lexaria ,Ioscience ,Orp ,Eleases ,Nnual ,Setter ,Rom ,